These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29437916)

  • 21. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.
    Stevens E; Carss KJ; Cirak S; Foley AR; Torelli S; Willer T; Tambunan DE; Yau S; Brodd L; Sewry CA; Feng L; Haliloglu G; Orhan D; Dobyns WB; Enns GM; Manning M; Krause A; Salih MA; Walsh CA; Hurles M; Campbell KP; Manzini MC; ; Stemple D; Lin YY; Muntoni F
    Am J Hum Genet; 2013 Mar; 92(3):354-65. PubMed ID: 23453667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exclusion of WWP1 mutations in a cohort of dystroglycanopathy patients.
    Godfrey C; Clement E; Abbs S; Muntoni F
    Muscle Nerve; 2011 Sep; 44(3):388-92. PubMed ID: 21996799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel mutations in the C-terminal region of GMPPB causing limb-girdle muscular dystrophy overlapping with congenital myasthenic syndrome.
    Luo S; Cai S; Maxwell S; Yue D; Zhu W; Qiao K; Zhu Z; Zhou L; Xi J; Lu J; Beeson D; Zhao C
    Neuromuscul Disord; 2017 Jun; 27(6):557-564. PubMed ID: 28433477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital muscular dystrophies in the UK population: Clinical and molecular spectrum of a large cohort diagnosed over a 12-year period.
    Sframeli M; Sarkozy A; Bertoli M; Astrea G; Hudson J; Scoto M; Mein R; Yau M; Phadke R; Feng L; Sewry C; Fen ANS; Longman C; McCullagh G; Straub V; Robb S; Manzur A; Bushby K; Muntoni F
    Neuromuscul Disord; 2017 Sep; 27(9):793-803. PubMed ID: 28688748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiling of the muscle-specific dystroglycan interactome reveals the role of Hippo signaling in muscular dystrophy and age-dependent muscle atrophy.
    Yatsenko AS; Kucherenko MM; Xie Y; Aweida D; Urlaub H; Scheibe RJ; Cohen S; Shcherbata HR
    BMC Med; 2020 Jan; 18(1):8. PubMed ID: 31959160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limb-girdle muscular dystrophy due to GMPPB mutations: A case report and comprehensive literature review.
    Sun L; Shen D; Xiong T; Zhou Z; Lu X; Cui F
    Bosn J Basic Med Sci; 2020 May; 20(2):275-280. PubMed ID: 30684953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
    Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
    Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A fourth case of POMT2-related limb girdle muscle dystrophy with mild reduction of α-dystroglycan glycosylation.
    Saredi S; Gibertini S; Ardissone A; Fusco I; Zanotti S; Blasevich F; Morandi L; Moroni I; Mora M
    Eur J Paediatr Neurol; 2014 May; 18(3):404-8. PubMed ID: 24183756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variations and clinical spectrum of dystroglycanopathy in a large cohort of Chinese patients.
    Song D; Dai Y; Chen X; Fu X; Chang X; Wang N; Zhang C; Yan C; Zheng H; Wu L; Jiang L; Hua Y; Yang H; Wang Z; Dai T; Zhu W; Han C; Yuan Y; Kobayashi K; Toda T; Xiong H
    Clin Genet; 2021 Mar; 99(3):384-395. PubMed ID: 33200426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Broad spectrum of phenotype and genotype in Korean α-dystroglycan related muscular dystrophy presenting to a tertiary pediatric neuromuscular center.
    Ko YJ; Cho A; Kim WJ; Kim SY; Lim BC; Kim H; Hwang H; Choi JE; Kim KJ; Chae JH
    Neuromuscul Disord; 2023 May; 33(5):425-431. PubMed ID: 37087885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital muscular dystrophy with muscle inflammation alpha dystroglycan glycosylation defect and no mutation in FKRP gene.
    Lamperti C; Cagliani R; Ciscato P; Moroni I; Viri M; Romeo A; Fagiolari G; Prelle A; Comi GP; Bresolin N; Moggio M
    J Neurol Sci; 2006 Apr; 243(1-2):47-51. PubMed ID: 16386759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycosylation defects in muscular dystrophies.
    Haliloğlu G; Topaloğlu H
    Curr Opin Neurol; 2004 Oct; 17(5):521-7. PubMed ID: 15367856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan.
    Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I
    Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel POMT2 mutation causes mild congenital muscular dystrophy with normal brain MRI.
    Murakami T; Hayashi YK; Ogawa M; Noguchi S; Campbell KP; Togawa M; Inoue T; Oka A; Ohno K; Nonaka I; Nishino I
    Brain Dev; 2009 Jun; 31(6):465-8. PubMed ID: 18804929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression.
    Kanagawa M; Yu CC; Ito C; Fukada S; Hozoji-Inada M; Chiyo T; Kuga A; Matsuo M; Sato K; Yamaguchi M; Ito T; Ohtsuka Y; Katanosaka Y; Miyagoe-Suzuki Y; Naruse K; Kobayashi K; Okada T; Takeda S; Toda T
    Hum Mol Genet; 2013 Aug; 22(15):3003-15. PubMed ID: 23562821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometry for the analysis of α-dystroglycan glycosylation in fibroblasts from patients with dystroglycanopathies.
    Stevens E; Torelli S; Feng L; Phadke R; Walter MC; Schneiderat P; Eddaoudi A; Sewry CA; Muntoni F
    PLoS One; 2013; 8(7):e68958. PubMed ID: 23894383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
    Murakami T; Nishino I
    Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in GMPPB Presenting with Pseudometabolic Myopathy.
    Panicucci C; Fiorillo C; Moro F; Astrea G; Brisca G; Trucco F; Pedemonte M; Lanteri P; Sciarretta L; Minetti C; Santorelli FM; Bruno C
    JIMD Rep; 2018; 38():23-31. PubMed ID: 28456886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and electrophysiological evaluation of myasthenic features in an alpha-dystroglycanopathy cohort (FKRP-predominant).
    Gonzalez-Perez P; Smith C; Sebetka WL; Gedlinske A; Perlman S; Mathews KD
    Neuromuscul Disord; 2020 Mar; 30(3):213-218. PubMed ID: 32115343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoglycosylation of dystroglycan due to T192M mutation: a molecular insight behind the fact.
    Bhattacharya S; Das A; Ghosh S; Dasgupta R; Bagchi A
    Gene; 2014 Mar; 537(1):108-14. PubMed ID: 24361964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.